Cash & equivalents decreased 36.9%
Cash & equivalents changed -36.9% from the comparable as-filed period.
$73.1M→$46.1M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ORGO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income decreased 925.0%
Net income changed -925.0% from the comparable as-filed period.
-$9.4M→-$96.3M2 prior comparisons
Operating income decreased 305.5%
Operating income changed -305.5% from the comparable as-filed period.
-$12.6M→-$51.0M3 prior comparisons
Operating margin moved 10409 bp lower
Operating margin changed -10409 basis points from the comparable as-filed period.
-12.45%→-116.54%3 prior comparisons
Research & development increased 76.0%
Research & development changed +76.0% from the comparable as-filed period.
$10.4M→$18.3M3 prior comparisons
Revenue decreased 56.7%
Revenue changed -56.7% from the comparable as-filed period.
$101.0M→$43.8M3 prior comparisons
Selling, general & administrative decreased 26.9%
Selling, general & administrative changed -26.9% from the comparable as-filed period.
$73.8M→$54.0M3 prior comparisons
Inventory decreased 11.4%
Inventory changed -11.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$33.0M→$29.3M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.